[HTML][HTML] HIF hydroxylation and the mammalian oxygen-sensing pathway
M Safran, WG Kaelin - The Journal of clinical investigation, 2003 - Am Soc Clin Investig
M Safran, WG Kaelin
The Journal of clinical investigation, 2003•Am Soc Clin InvestigNonstandard abbreviations used: erythropoietin (EPO); hypoxia-inducible factor (HIF); aryl
hydrocarbon receptor nuclear translocator (ARNT); basic helix-loop-helix (bHLH);
Per/Arnt/Sim (PAS); glucose transporter 1 (GLUT1); CREB-binding protein (CBP); von
Hippel–Lindau (VHL); RING box protein 1 (Rbx1); Skp1/Cdc53/F-box (SCF);
oxygendependent degradation domain (ODD); egg laying nine (EGLN); prolyl hydroxylase
domain (PHD); N-terminal transactivation domain (N-TAD); C-terminal transactivation …
hydrocarbon receptor nuclear translocator (ARNT); basic helix-loop-helix (bHLH);
Per/Arnt/Sim (PAS); glucose transporter 1 (GLUT1); CREB-binding protein (CBP); von
Hippel–Lindau (VHL); RING box protein 1 (Rbx1); Skp1/Cdc53/F-box (SCF);
oxygendependent degradation domain (ODD); egg laying nine (EGLN); prolyl hydroxylase
domain (PHD); N-terminal transactivation domain (N-TAD); C-terminal transactivation …
Nonstandard abbreviations used: erythropoietin (EPO); hypoxia-inducible factor (HIF); aryl hydrocarbon receptor nuclear translocator (ARNT); basic helix-loop-helix (bHLH); Per/Arnt/Sim (PAS); glucose transporter 1 (GLUT1); CREB-binding protein (CBP); von Hippel–Lindau (VHL); RING box protein 1 (Rbx1); Skp1/Cdc53/F-box (SCF); oxygendependent degradation domain (ODD); egg laying nine (EGLN); prolyl hydroxylase domain (PHD); N-terminal transactivation domain (N-TAD); C-terminal transactivation domain (C-TAD); factor-inhibiting HIF1 (FIH1).
The Journal of Clinical Investigation